GILD logo

Gilead Sciences (GILD) Cash and cash equivalents

annual cash & cash equivalents:

$9.99B+$3.91B(+64.19%)
December 31, 2024

Summary

  • As of today (May 29, 2025), GILD annual cash & cash equivalents is $9.99 billion, with the most recent change of +$3.91 billion (+64.19%) on December 31, 2024.
  • During the last 3 years, GILD annual cash & cash equivalents has risen by +$4.65 billion (+87.17%).
  • GILD annual cash & cash equivalents is now -44.31% below its all-time high of $17.94 billion, reached on December 31, 2018.

Performance

GILD Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDbalance sheet metrics

quarterly cash & cash equivalents:

$7.93B-$2.06B(-20.67%)
March 1, 2025

Summary

  • As of today (May 29, 2025), GILD quarterly cash & cash equivalents is $7.93 billion, with the most recent change of -$2.06 billion (-20.67%) on March 1, 2025.
  • Over the past year, GILD quarterly cash & cash equivalents has increased by +$3.21 billion (+67.99%).
  • GILD quarterly cash & cash equivalents is now -55.82% below its all-time high of $17.94 billion, reached on December 31, 2018.

Performance

GILD quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

GILD Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+64.2%+68.0%
3 y3 years+87.2%+84.5%
5 y5 years-14.1%-21.1%

GILD Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+87.2%-20.7%+185.9%
5 y5-year-14.1%+87.2%-38.5%+185.9%
alltimeall time-44.3%>+9999.0%-55.8%>+9999.0%

GILD Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$7.93B(-20.7%)
Dec 2024
$9.99B(+64.2%)
$9.99B(+98.4%)
Sep 2024
-
$5.04B(+81.7%)
Jun 2024
-
$2.77B(-41.2%)
Mar 2024
-
$4.72B(-22.5%)
Dec 2023
$6.08B(+12.4%)
$6.08B(+6.7%)
Sep 2023
-
$5.71B(+0.0%)
Jun 2023
-
$5.70B(+15.6%)
Mar 2023
-
$4.94B(-8.8%)
Dec 2022
$5.41B(+1.4%)
$5.41B(+15.2%)
Sep 2022
-
$4.70B(-0.8%)
Jun 2022
-
$4.74B(+10.3%)
Mar 2022
-
$4.30B(-19.5%)
Dec 2021
$5.34B(-11.0%)
$5.34B(+22.4%)
Sep 2021
-
$4.36B(-10.9%)
Jun 2021
-
$4.89B(+20.4%)
Mar 2021
-
$4.07B(-32.2%)
Dec 2020
$6.00B(-48.4%)
$6.00B(-53.5%)
Sep 2020
-
$12.89B(+91.0%)
Jun 2020
-
$6.75B(-32.9%)
Mar 2020
-
$10.05B(-13.6%)
Dec 2019
$11.63B(-35.2%)
$11.63B(+22.8%)
Sep 2019
-
$9.47B(-15.7%)
Jun 2019
-
$11.24B(-33.6%)
Mar 2019
-
$16.93B(-5.6%)
Dec 2018
$17.94B(+136.4%)
$17.94B(+23.1%)
Sep 2018
-
$14.57B(+10.1%)
Jun 2018
-
$13.23B(+73.2%)
Mar 2018
-
$7.64B(+0.7%)
Dec 2017
$7.59B(-7.8%)
$7.59B(-34.1%)
Sep 2017
-
$11.51B(+32.1%)
Jun 2017
-
$8.71B(-15.3%)
Mar 2017
-
$10.29B(+25.0%)
Dec 2016
$8.23B(-36.0%)
$8.23B(-16.1%)
Sep 2016
-
$9.81B(+51.3%)
Jun 2016
-
$6.49B(+2.7%)
Mar 2016
-
$6.32B(-50.9%)
Dec 2015
$12.85B(+28.2%)
$12.85B(-8.0%)
Sep 2015
-
$13.96B(+88.3%)
Jun 2015
-
$7.42B(-30.3%)
Mar 2015
-
$10.63B(+6.1%)
Dec 2014
$10.03B(+374.5%)
$10.03B(+61.5%)
Sep 2014
-
$6.21B(-28.9%)
Jun 2014
-
$8.73B(+36.3%)
Mar 2014
-
$6.40B(+203.1%)
Dec 2013
$2.11B(+17.1%)
$2.11B(+5.1%)
Sep 2013
-
$2.01B(-8.7%)
Jun 2013
-
$2.20B(+18.1%)
Mar 2013
-
$1.86B(+3.3%)
Dec 2012
$1.80B(-81.8%)
$1.80B(+16.3%)
Sep 2012
-
$1.55B(-4.6%)
Jun 2012
-
$1.63B(+12.0%)
Mar 2012
-
$1.45B(-85.3%)
Dec 2011
$9.88B(+988.7%)
$9.88B(+986.9%)
Sep 2011
-
$909.36M(+0.4%)
Jun 2011
-
$905.78M(-50.7%)
Mar 2011
-
$1.84B(+102.2%)
Dec 2010
$907.88M(-28.7%)
$907.88M(-11.3%)
Sep 2010
-
$1.02B(-31.0%)
Jun 2010
-
$1.48B(+58.3%)
Mar 2010
-
$936.88M(-26.4%)
Dec 2009
$1.27B(-12.8%)
$1.27B(+24.2%)
Sep 2009
-
$1.02B(-1.6%)
Jun 2009
-
$1.04B(-37.4%)
Mar 2009
-
$1.66B(+14.0%)
Dec 2008
$1.46B
$1.46B(+20.7%)
Sep 2008
-
$1.21B(+8.0%)
DateAnnualQuarterly
Jun 2008
-
$1.12B(+54.9%)
Mar 2008
-
$722.88M(-25.3%)
Dec 2007
$968.09M(+18.6%)
$968.09M(+65.7%)
Sep 2007
-
$584.13M(-16.7%)
Jun 2007
-
$701.65M(-3.8%)
Mar 2007
-
$729.14M(-10.6%)
Dec 2006
$816.01M(+15.3%)
$816.01M(+45.8%)
Sep 2006
-
$559.58M(-36.7%)
Jun 2006
-
$884.45M(+229.2%)
Mar 2006
-
$268.68M(-62.0%)
Dec 2005
$707.91M(+152.0%)
$707.91M(+19.4%)
Sep 2005
-
$592.72M(-25.3%)
Jun 2005
-
$793.62M(+181.5%)
Mar 2005
-
$281.94M(+0.4%)
Dec 2004
$280.91M(+44.3%)
$280.91M(-6.8%)
Sep 2004
-
$301.45M(+33.1%)
Jun 2004
-
$226.56M(+45.6%)
Mar 2004
-
$155.59M(-20.1%)
Dec 2003
$194.72M(-68.4%)
$194.72M(+88.5%)
Sep 2003
-
$103.32M(-39.0%)
Jun 2003
-
$169.35M(+44.2%)
Mar 2003
-
$117.48M(-81.0%)
Dec 2002
$616.93M(+399.6%)
$616.93M(+407.3%)
Sep 2002
-
$121.61M(-0.3%)
Jun 2002
-
$122.01M(+6.0%)
Mar 2002
-
$115.09M(-6.8%)
Dec 2001
$123.49M(-37.4%)
$123.49M(+230.7%)
Sep 2001
-
$37.35M(-20.4%)
Jun 2001
-
$46.92M(-39.4%)
Mar 2001
-
$77.40M(-60.8%)
Dec 2000
$197.29M(+319.7%)
$197.29M(+354.9%)
Sep 2000
-
$43.37M(+1.5%)
Jun 2000
-
$42.74M(+14.6%)
Mar 2000
-
$37.30M(-20.7%)
Dec 1999
$47.01M(-53.5%)
$47.01M(-33.6%)
Sep 1999
-
$70.80M(+56.3%)
Jun 1999
-
$45.30M(-22.4%)
Mar 1999
-
$58.40M(-42.2%)
Dec 1998
$101.10M(+215.9%)
$101.10M(+134.0%)
Sep 1998
-
$43.20M(+16.8%)
Jun 1998
-
$37.00M(+7.9%)
Mar 1998
-
$34.30M(+7.2%)
Dec 1997
$32.00M(-75.8%)
$32.00M(-30.0%)
Sep 1997
-
$45.70M(-67.1%)
Jun 1997
-
$139.00M(+32.8%)
Mar 1997
-
$104.70M(-20.7%)
Dec 1996
$132.00M(+381.8%)
$132.00M(-15.4%)
Sep 1996
-
$156.00M(-14.7%)
Jun 1996
-
$182.90M(+270.2%)
Mar 1996
-
$49.40M(-31.8%)
Dec 1995
$27.40M(-9.9%)
-
Sep 1995
-
$72.40M(+751.8%)
Jun 1995
-
$8.50M(-72.0%)
Mar 1995
-
$30.40M(+98.7%)
Mar 1995
$30.40M(+133.8%)
-
Dec 1994
-
$15.30M(-42.5%)
Sep 1994
-
$26.60M(-39.1%)
Jun 1994
-
$43.70M(+236.2%)
Mar 1994
$13.00M(+519.0%)
$13.00M(+51.2%)
Dec 1993
-
$8.60M(+309.5%)
Sep 1993
-
$2.10M(-40.0%)
Jun 1993
-
$3.50M(+66.7%)
Mar 1993
$2.10M(-97.6%)
$2.10M(-95.6%)
Dec 1992
-
$47.80M(+1978.3%)
Sep 1992
-
$2.30M(-87.2%)
Jun 1992
-
$17.90M(-79.6%)
Mar 1992
$87.90M(+753.4%)
$87.90M(+753.4%)
Mar 1991
$10.30M
$10.30M

FAQ

  • What is Gilead Sciences annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Gilead Sciences?
  • What is Gilead Sciences annual cash & cash equivalents year-on-year change?
  • What is Gilead Sciences quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Gilead Sciences?
  • What is Gilead Sciences quarterly cash & cash equivalents year-on-year change?

What is Gilead Sciences annual cash & cash equivalents?

The current annual cash & cash equivalents of GILD is $9.99B

What is the all time high annual cash & cash equivalents for Gilead Sciences?

Gilead Sciences all-time high annual cash & cash equivalents is $17.94B

What is Gilead Sciences annual cash & cash equivalents year-on-year change?

Over the past year, GILD annual cash & cash equivalents has changed by +$3.91B (+64.19%)

What is Gilead Sciences quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of GILD is $7.93B

What is the all time high quarterly cash & cash equivalents for Gilead Sciences?

Gilead Sciences all-time high quarterly cash & cash equivalents is $17.94B

What is Gilead Sciences quarterly cash & cash equivalents year-on-year change?

Over the past year, GILD quarterly cash & cash equivalents has changed by +$3.21B (+67.99%)
On this page